Company / Income Tax per Share
Jazz Pharmaceuticals Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$4.49
FY2025
5-year range
-$4.49 / $0.54
FY2021-FY2025
Trend
-206.0%
vs FY2024
Sector context
#200 of 201
Health Care
What the data says
Income Tax per Share changed -206% YoY in FY2025, a notable deviation from the 9-year average annual change of -34%.
Based on SEC 10-K filings.
-4.49 in FY2025.
Improved from $-1.90 to $-4.49 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 201This company -$4.49 Sector average $1.35
▼
-433.3% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 206.0% year-over-year.
- Ranks #200 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.49 | -206.0% |
| FY2024 | -$1.47 | +22.6% |
| FY2023 | -$1.90 | -448.8% |
| FY2022 | $0.54 | +141.8% |
| FY2021 | -$1.30 | -191.2% |
| FY2020 | $1.43 | +272.6% |
| FY2019 | -$0.83 | -136.0% |
| FY2018 | $2.30 | +387.7% |
| FY2017 | -$0.80 | -151.9% |
| FY2016 | $1.54 | -12.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026